Blog

For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Has New Oriental Education (EDU) been one of

For those looking to find strong Utilities stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Energias de Portugal (EDPFY) one of those stocks right

For those looking to find strong Retail-Wholesale stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Dillard's (DDS) one of those stocks right now? By

Jack Henry & Associates, Inc. JKHY shares gained 4.7% during Tuesday’s extended trading session after the company reported better-than-expected second-quarter fiscal 2026 results. The company

Major U.S. stock market indices slipped on Feb. 3, as a tech sell-off rippled through Wall Street. Software stocks, already under pressure, took another hit after AI startup Anthropic rolled out new

• NVIDIA Corporation’s NVDA shares declined 2.8%, falling for a third straight session due to the broad tech sell-off and continued uncertainty surrounding its OpenAI investment.
• Shares of Illinois

On Feb. 2, before market open, the Walt Disney Company DIS reported first-quarter fiscal 2026 adjusted earnings of $1.63 per share, which beat the Zacks Consensus Estimate by 3.8% but decreased 7%

A downtrend has been apparent in Autodesk (ADSK) lately with too much selling pressure. The stock has declined 17.9% over the past four weeks. However, given the fact that it is now in oversold

A downtrend has been apparent in J&J Snack Foods (JJSF) lately with too much selling pressure. The stock has declined 11% over the past four weeks. However, given the fact that it is now in oversold

Genpact (G) has been on a downward spiral lately with significant selling pressure. After declining 17.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now

A downtrend has been apparent in S&P Global (SPGI) lately with too much selling pressure. The stock has declined 13.2% over the past four weeks. However, given the fact that it is now in oversold

Epam (EPAM) has been beaten down lately with too much selling pressure. While the stock has lost 16.1% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Amdocs Limited DOX shares gained 4% during Tuesday’s extended trading session after the company reported better-than-expected first-quarter fiscal 2026 results. DOX’s non-GAAP earnings of $1.81 per

Bio-Techne Corporation TECH reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of 46 cents, which surpassed the Zacks Consensus Estimate by 8.2%. The bottom line was up 9.5% on a

U.S. President Donald Trump recently launched “Project Vault,” a $12 billion strategic stockpile of critical and rare earth minerals aimed at insulating U.S. manufacturers from supply shocks. The

Swiss pharma giant Novartis AG NVS reported fourth-quarter core earnings per share (excluding one-time charges) of $2.03, which beat the Zacks Consensus Estimate of $1.99. The figure was also up

Wall Street closed sharply lower on Tuesday, pulled down by tech and healthcare stocks. Investor mood was grim as tech stocks slid on valuation and AI-spending worries, while healthcare names fell

CDW Corporation CDW reported fourth-quarter 2025 non-GAAP earnings per share (EPS) of $2.57, beating the Zacks Consensus Estimate of $2.44. Also, the bottom line increased 3.8% year over year.

CDW

Silgan Holdings (SLGN) reported $1.47 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 4.1%. EPS of $0.67 for the same period compares to $0.85 a

Boston Scientific (BSX) reported $5.29 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 15.9%. EPS of $0.80 for the same period compares to $0.70 a

For the quarter ended December 2025, Evercore (EVR) reported revenue of $1.3 billion, up 32.4% over the same period last year. EPS came in at $5.13, compared to $3.41 in the year-ago quarter.

The

Lear (LEA) reported $5.99 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 4.8%. EPS of $3.41 for the same period compares to $2.94 a year ago.

The

T. Rowe Price (TROW) reported $1.93 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 6%. EPS of $2.44 for the same period compares to $2.12 a year

For the quarter ended December 2025, Bunge Global (BG) reported revenue of $23.76 billion, up 75.5% over the same period last year. EPS came in at $1.99, compared to $2.13 in the year-ago quarter.

GE HealthCare Technologies (GEHC) reported $5.7 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 7.1%. EPS of $1.44 for the same period compares to